Pfizer shares rise on generic Lipitor deal
Pfizer shares gain as the drugmaker reaches agreement to allow India's Ranbaxy Labs to market a generic version of Lipitor, Pfizer's best-selling product, in 2011. 5 months ago
MarketWatch Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook